Pendal Group Ltd VRTX β€” VERTEX PHARMACEUTICALS INC

Ownership history in Pendal Group Ltd  Β·  18 quarters on record

AI Ownership Summary

Pendal Group Ltd reported VERTEX PHARMACEUTICALS INC (VRTX) in 18 quarterly 13F filings .

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this VRTX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Pendal Group Ltd's position in VERTEX PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
β€”

See the most recent quarter where the fund disclosed this position.

High-water mark
Peak Conviction
β€”

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
18 quarters

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

VRTX stock page Pendal Group Ltd fund profile Pendal Group Ltd full holdings
How Pendal Group Ltd held VRTX β€” position size vs. price
% of Fund (quarterly)    VRTX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
πŸ“‹ Quarterly Holdings History 0 quarters  β–Ύ
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
18 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding VRTX

As of 2026 Q1 β€” sorted by position size

Andrew Hill Investment Advisors, Inc. 3Y 4.76% Eurizon SLJ Capital Ltd 4.54% Sivik Global Healthcare LLC 3Y 7Y 3.39% NIA IMPACT ADVISORS, LLC 3Y 3.08% Birch Hill Investment Advisors LLC 3Y 7Y 3.02% BENDER ROBERT & ASSOCIATES 3Y 7Y 2.8% Shelter Mutual Insurance Co 3Y 7Y 2.74% AlphaCentric Advisors LLC 3Y 2.2% Private Harbour Investment Management & Counsel, LLC 3Y 7Y 2.15% B. Metzler seel. Sohn & Co. AG 3Y 2.12%

FAQ About Pendal Group Ltd and VRTX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Pendal Group Ltd reported owning VRTX?

Pendal Group Ltd reported VRTX across 0 quarterly 13F filings.

What was the largest reported VRTX position in Pendal Group Ltd's portfolio?

This page shows the quarter-by-quarter portfolio weight history for VRTX in Pendal Group Ltd.

What is the latest reported VRTX position on this page?

The most recent filing on this page is 2022 Q4, when Pendal Group Ltd reported 297,723 shares, equal to 0.74% of portfolio, with an estimated market value of $86.0M.

What does the chart on this VRTX ownership page compare?

The chart compares Pendal Group Ltd's quarterly VRTX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Pendal Group Ltd time their VRTX position?

Based on 13F filing dates vs. subsequent VRTX price moves, Pendal Group Ltd correctly timed 6 out of 17 reported position changes (35%). The annualised alpha on VRTX relative to SPY over the holding period was -1.0%.

← Back to Pendal Group Ltd Holdings